LY315920NA/S-5920, a selective inhibitor of group IIA secretory phospholipase A2, fails to improve clinical outcome for patients with severe sepsis. - Zeiher,B.G.; Steingrub,J.; Laterre,P.F.; Dmitrienko,A.; Fukiishi,Y.; Abraham,E. (Crit Care Med, 2005)